These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7898166)

  • 1. [Serum adenosine deaminase and hepatitis C virus infection].
    Fernández E; Riestra S; Rodríguez S; Rodríguez M
    Med Clin (Barc); 1995 Feb; 104(4):158. PubMed ID: 7898166
    [No Abstract]   [Full Text] [Related]  

  • 2. Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan.
    Achakzai M; Kassi M; Kasi PM
    Trop Doct; 2007 Jan; 37(1):43-5. PubMed ID: 17326891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter evaluation of hepatitis C RNA levels among female injection drug users.
    Thomas DL; Rich JD; Schuman P; Smith DK; Astemborski JA; Nolt KR; Klein RS
    J Infect Dis; 2001 Mar; 183(6):973-6. PubMed ID: 11237816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
    Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adenosine deaminase levels in intravenous drug users with and without infection due to human immunodeficiency virus.
    Iñigo MA; López de Tejada MR; Torres-Tortosa M; Sánchez-Porto A
    Clin Infect Dis; 1994 Mar; 18(3):478-9. PubMed ID: 8011844
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum adenosine deaminase enzyme and plasma platelet factor 4 activities in active pulmonary tuberculosis, HIV-seropositive subjects and cancer patients.
    Tarhan G; Gümüşlü F; Yilmaz N; Saka D; Ceyhan I; Cesur S
    J Infect; 2006 Apr; 52(4):264-8. PubMed ID: 16102836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial spontaneous clearance and re-infection with a distinct hepatitis C virus genotype leading to chronic hepatitis C in an HIV+ intravenous drug user.
    Vispo E; Martinez-Alarcon J; Poveda E; Toro C; Soriano V
    AIDS; 2008 Jan; 22(2):318. PubMed ID: 18097239
    [No Abstract]   [Full Text] [Related]  

  • 10. Low prevalence of hepatitis C virus infection among human immunodeficiency virus type 1-infected individuals from Slovenia and Croatia.
    Seme K; Poljak M; Begovac J; Vince A; Tomazic J; Vidmar L; Kniewald T
    Acta Virol; 2002; 46(2):91-4. PubMed ID: 12387500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N; Arora U; Singh K
    Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
    Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
    Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
    Kresina TF; Bruce RD; Cargill VA; Cheever LW
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary hypertension in HIV-infected patients].
    Léautez S; Boutoille D; Renard B; Esnault JL; Raffi F
    Rev Mal Respir; 2001 Sep; 18(4 Pt 1):432-5. PubMed ID: 11547253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication.
    Laskus T; Radkowski M; Wang LF; Jang SJ; Vargas H; Rakela J
    Virology; 1998 Aug; 248(1):164-71. PubMed ID: 9705266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyrin abnormalities in acquired immunodeficiency syndrome.
    O'Connor WJ; Murphy GM; Darby C; Fogarty J; Mulcahy F; O'Moore R; Barnes L
    Arch Dermatol; 1996 Dec; 132(12):1443-7. PubMed ID: 8961872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal hepatitis C virus transmission--role of human immunodeficiency virus infection and injection drug use.
    Armstrong GL; Perz JF; Alter MJ
    J Infect Dis; 2003 Mar; 187(5):872; author reply 872-4. PubMed ID: 12599064
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
    Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
    J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hepatitis C virus really have no effect on survival in cases of infection with human immunodeficiency virus?
    Jenny-Avital ER
    Clin Infect Dis; 2000 Feb; 30(2):409-10. PubMed ID: 10671362
    [No Abstract]   [Full Text] [Related]  

  • 20. Treating hepatitis C virus infection in active substance users.
    Sylvestre DL
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S321-4. PubMed ID: 15768341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.